Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |